300122.SZ Stock Analysis
30
Uncovered
Chongqing Zhifei Biological Products Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Market cap $B
6.932
Dividend yield
2.95 %
Shares outstanding
2 274.57 B
Chongqing Zhifei Biological Products Co., Ltd. engages in the wholesale of biological products and vaccines. The company is headquartered in Chongqing, Chongqing and currently employs 4,800 full-time employees. The company went IPO on 2010-09-28. The firm's main products include bacterial vaccines for the prevention of meningitis and pneumonia-based bacteria, biological products for the prevision and treatment of tuberculosis, viral vaccines for the prevention of rabies virus, influenza virus and other virus, general drugs and other biological products, among others. The firm is also involved in the agency sale of vaccines. The firm distributes its products in domestic market and to overseas markets, with Central China as its main market.